BiotechTube
Home/Dianthus Therapeutics/Nenad Tomasevic
NT

Nenad Tomasevic

Chief Scientific Officer

Dianthus Therapeutics

Therapeutic Areas

Autoimmune DiseasesNeurologyRare Diseases

Dianthus Therapeutics Pipeline

DrugIndicationPhase
DNTH103Generalized Myasthenia Gravis (gMG)Phase 1
Next-generation complement inhibitorsUndisclosed autoimmune indicationsDiscovery

Leadership Team at Dianthus Therapeutics

MG
Marino Garcia
Chief Executive Officer
SS
Simona Skerjanec
Chief Operating Officer
NK
Nerissa Kreher
Chief Medical Officer
RS
Ryan Savitz
Chief Financial Officer
View full Dianthus Therapeutics profile